Friedberg Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-6,765
| Closed | -$512K | – | 71 |
|
|
2017
Q2 | $512K | Sell |
6,765
-2,885
| -30% | -$218K | 0.22% | 74 |
|
|
2017
Q1 | $637K | Buy |
9,650
+753
| +8% | +$49.7K | 0.27% | 77 |
|
|
2016
Q4 | $563K | Sell |
8,897
-400
| -4% | -$25.3K | 0.26% | 79 |
|
|
2016
Q3 | $591K | Buy |
9,297
+3,510
| +61% | +$223K | 0.25% | 83 |
|
|
2016
Q2 | $430K | Buy |
+5,787
| New | +$430K | 0.2% | 82 |
|